Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX – Get Free Report) gapped up before the market opened on Thursday . The stock had previously closed at $15.61, but opened at $16.15. Telix Pharmaceuticals Limited American Depositary Shares shares last traded at $15.70, with a volume of 738 shares traded.
Wall Street Analyst Weigh In
A number of brokerages recently commented on TLX. UBS Group began coverage on Telix Pharmaceuticals Limited American Depositary Shares in a report on Friday, November 15th. They issued a “buy” rating and a $21.00 price target for the company. William Blair upgraded Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a research note on Tuesday, November 19th.
Read Our Latest Stock Analysis on TLX
Telix Pharmaceuticals Limited American Depositary Shares Stock Up 4.9 %
About Telix Pharmaceuticals Limited American Depositary Shares
Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.
Featured Stories
- Five stocks we like better than Telix Pharmaceuticals Limited American Depositary Shares
- How to Calculate Inflation Rate
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- How to Invest in the FAANG Stocks
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- What is a support level?
- MarketBeat Week in Review – 01/13 – 01/17
Receive News & Ratings for Telix Pharmaceuticals Limited American Depositary Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Telix Pharmaceuticals Limited American Depositary Shares and related companies with MarketBeat.com's FREE daily email newsletter.
